| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 32,172 | 32,111 | 28,472 | 36,695 | | Cost of Revenue | 17,695 | 18,471 | 17,352 | 21,785 | | | Gross Profit | 14,477 | 13,640 | 11,120 | 14,910 | | | Operating Expenses | | Research Development | 4,221 | 4,634 | 4,551 | 4,395 | | Selling General and Administrative | 10,786 | 11,264 | 11,185 | 12,042 | | Non Recurring | 1,044 | 29 | 23 | 45,304 | | Others | 1,548 | 1,557 | 1,557 | 1,592 | | | | Total Operating Expenses | 17,599 | 17,484 | 17,316 | 63,333 | | | | Operating Income or Loss | (3,122) | (3,844) | (6,196) | (48,423) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (85) | 66 | (183) | 2,991 | | Earnings Before Interest And Taxes | (3,742) | (3,778) | (6,379) | (45,432) | | Interest Expense | (391) | 179 | 212 | 469 | | Income Before Tax | (3,351) | (3,957) | (6,591) | (45,901) | | Income Tax Expense | 26 | 96 | 54 | 378 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,377) | (4,053) | (6,645) | (46,279) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,377) | (4,053) | (6,645) | (46,279) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,377) | ($4,053) | ($6,645) | ($46,279) |
|
0.13% Nasdaq 
Income Statement
